Canada turmoil, stock-market politics, a scandal in Norway, ballerinas and food, W. B. Yeats, and more.

Fzata, Inc. announces the execution of a clinical trial agreement with the National Institutes of Health (NIH) to sponsor a ...

Clostridioides difficile infection is a major healthcare-associated infection, causing significant morbidity and mortality, ...

Meanwhile, A new report from the Health Protection Surveillance Centre (HPSC) found that 605 cases of C diff were reported ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality rates, especially in vulnerable populations. CDI ...

A Novel First-in-Class Microbiome-Restoration Therapy for the Prevention of Recurrence of C. diff Infection Ferring's novel first-in-class REBYOTA is indicated for the prevention of recurrence of ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

A Novel First-in-Class Microbiome-Restoration Therapy for the Prevention of Recurrence of C. diff Infection Ferring's novel first-in-class REBYOTA is indicated for the prevention of recurrence of ...

A new UConn study reveals that tagatose, a plant-based sugar alternative, shows promise in mitigating Clostridioides difficile (C. difficile) infection, particularly those resistant to antibiotics.

Additionally, the long data collection period involved changes in treatment models for IBD and C difficile infection, which may have influenced the results. No financial support was reported for ...